Neurodevelopment at 11 months after starting antiretroviral therapy within 3 weeks of life

Barbara Laughton1, Shalena Naidoo2, Els F M T Dobbels1

  • 1Department of Paediatrics and Child Health, Stellenbosch University, Cape Town, South Africa.

Insights

Starting antiretroviral therapy (ART) within days of birth in HIV-infected infants shows normal early neurodevelopment. This early intervention is crucial for positive outcomes in infants with perinatal HIV.

Area of Science:

  • Pediatric Infectious Diseases
  • Neurodevelopmental Pediatrics
  • Public Health

Background:

  • Antiretroviral therapy (ART) initiated between 7-12 weeks improves neurodevelopment in HIV-infected infants.
  • The effects of initiating ART even earlier, within 21 days of life, were not previously well-described.

Purpose of the Study:

  • To assess the early neurodevelopmental outcomes of human immunodeficiency virus (HIV)-positive infants who commenced ART within 21 days of birth.
  • To evaluate the impact of very early ART initiation on infant neurodevelopment.

Main Methods:

  • Infants were enrolled from a public sector HIV diagnosis program, meeting criteria for birth weight, early ART initiation (<6 weeks), and absence of cytomegalovirus disease.
  • ART regimens varied based on initial treatment and infant weight/gestational age, with Zidovudine/Lamivudine/Nevirapine followed by Lopinavir/Ritonavir, and later Abacavir substitution.
  • Neurodevelopment was assessed using the Griffiths Mental Development Scales (GMDS) between 10-12 months of age.

Main Results:

  • Twenty-nine HIV-infected infants were assessed, with 79% being female and 83% of mothers receiving ART during pregnancy.
  • ART was initiated at a median of 6 days, with viral load suppression achieved by a median of 19.1 weeks.
  • At 11.5 months, global and subscale neurodevelopmental quotients measured by GMDS were within the average range, despite 31% having detectable viral load at assessment.

Conclusions:

  • Very early initiation of ART (median 6 days) in infants with perinatal HIV infection is associated with neurodevelopmental scores within the normal range.
  • These preliminary findings in a small cohort suggest that timely ART commencement is beneficial for neurodevelopmental outcomes.
  • Further research with larger cohorts is warranted to confirm these positive early neurodevelopmental findings.
Abstract

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
49.1K
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
726
Retroviruses02:33

Retroviruses

Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
14.5K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
177